NCT00223171View on ClinicalTrials.gov

Duration of Androgen Blockade Combined With Pelvic Irradiation in Prostate Cancers

PHASE3Active, not recruitingINTERVENTIONAL

Enrollment

630

Participants

Timeline

Start Date

October 31, 2000

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions

Prostate Cancer

Interventions

DRUG

Androgen blockade + radiation therapy

Androgen blockade + radiation therapy

Trial Locations (1)

J1H 5N4

Centre de Recherche Clinique du CHUS, Sherbrooke

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

lead

Université de Sherbrooke

OTHER